로딩 중…
지수 로딩 중…
Revolution Medicines, Inc.
RVMD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$162.91+3.26%
2026-06-18
Price Chart
Revolution Medicines, Inc.+307.99%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $34.63B |
| Revenue | $0.00 |
| Net Income | $-1.37B |
| Total Assets | $2.25B |
| Net Assets | $1.50B |
| Value | |
| P/B | 23.09x |
| FCF Yield | -3.09% |
| Profitability | |
| ROE | -91.45% |
| ROA | -60.86% |
| Financial Health | |
| Debt Ratio | 50.26% |
| Total Debt | $157M |
| FCF | $-1.07B |
| Cash | $441M |
| Current Ratio | 6.80x |
| Performance | |
| 1Y Return | 307.99% |
| 1M Return | 10.60% |
| From 52W High | -2.16% |
| 1Y MDD | -24.95% |
| Trading | |
| Volume | 4,014,993 shares |
| Trading Value | $651M |
| Per Share | |
| EPS | $-5.95 |
| BPS | $8.58 |